Evidence map›Paper›PMID 23733800›Full record

ArticlePediatrics2013

Invasive pneumococcal disease in infants younger than 90 days before and after introduction of PCV7.

Liset Olarte, Krow Ampofo, Chris Stockmann, Edward O Mason, Judy A Daly, Andrew T Pavia, Carrie L Byington

Open access · greenAbstract read
In one paragraph

Article in Pediatrics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Prevention and Control of Childhood Pneumonia and Diarrhea.Pediatric clinics of North America · 2016
    Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Liset OlarteDivision of Pediatric Infectious Diseases, Department of Pediatrics, University of Utah Health Sciences Center, Salt Lake City, UT, USA.
Krow Ampofo
Chris Stockmann
Edward O Mason
Judy A Daly
Andrew T Pavia
Carrie L Byington
University of Utah · USBaylor College of Medicine · US

Funding

University of Utah Center for Clinical and Translational ScienceUL1TR001067 · NCATS · UNIVERSITY OF UTAH · PI DERE, WILLARD H., HESS, RACHEL · 2013 to 2017
$19.8M
UNIVERSITY OF UTAH CENTER FOR CLINICAL AND TRANSLATIONAL SCIENCE-UL1: BPCAUL1RR025764 · NCRR · UNIVERSITY OF UTAH · PI MCCLAIN, DONALD A. · 2008 to 2011
$19.4M
University of Utah Center for Clinical and Translational Science-UL1UL1TR000105 · NCATS · UNIVERSITY OF UTAH · PI MCCLAIN, DONALD A. · 2012 to 2013
$5.1M
FilmArray Biothreat Pathogens: An Automated Multiplex PCR Diagnostic SystemU01AI082184 · NIAID · BIOFIRE DEFENSE, LLC. · PI OTA, IRENE M · 2009 to 2010
$3.0M
Epidemiology and Etiology of Hospitalized Pneumonia in ChildrenU18IP000303 · IP · UNIVERSITY OF UTAH · PI AMPOFO, KROW · 2009 to 2010
$1.6M
NCATS NIH HHS 8UL1TR000105NCATS NIH HHS UL1 TR000105NCATS NIH HHS UL1 TR001067NCIRD CDC HHS U18 IP000303NCIRD CDC HHS U18-IP000303-01NCRR NIH HHS UL1 RR025764NIAID NIH HHS U01 AI082184NIAID NIH HHS U01AI082184-01
6 · The paper itself

Abstract

backgroundIntroduction of the heptavalent pneumococcal conjugate vaccine (PCV7) changed the epidemiology of invasive pneumococcal disease (IPD). We evaluated the changes that occurred after PCV7 introduction among Utah infants aged 1 to 90 days, too young to be fully immunized.

methodsWe identified children <18 years with culture-confirmed IPD from 1997-2010. We analyzed demographic, clinical, and serotype data for infants aged 1-90 days. The pre- and post-vaccine introduction periods spanned 1997-2000 and 2001-2010, respectively.

resultsOf 513 children with IPD, 36 were 1 to 90 days and accounted for 7% of IPD cases in both the pre- and post-vaccine introduction period. The pre-vaccine IPD incidence rate was 5.0 per 100 000 live births, and was unchanged in the post-vaccine introduction period. IPD caused by PCV7 serotypes decreased by 74% (from 2.2 to 0.58 per 100 000), whereas non-vaccine serotype IPD increased by 57% (from 2.8 to 4.4 per 100 000). Sixteen infants (44%) required intensive care, and 3 (8%) died. Bacteremia without focus (56%) and meningitis (44%) were the predominant syndromes in the pre- and post-vaccine introduction periods, respectively. In the post-vaccine introduction period, serotype 7F was the most common serotype among infants and was responsible for 50% of meningitis.

conclusionsThe incidence of IPD in Utah infants aged 1 to 90 days caused by PCV7 serotypes decreased after PCV7 introduction, but overall incidence was unchanged. In the post-vaccine introduction period, serotype 7F predominated in this age group and was associated with meningitis.

Indexed as

BacteremiaCritical CareCross-Sectional StudiesFemaleHeptavalent Pneumococcal Conjugate VaccineHumansIncidenceInfantInfant, NewbornMaleMeningitis, PneumococcalPneumococcal InfectionsPneumococcal VaccinesPolysaccharides, BacterialSerotypingStreptococcus pneumoniaeHeptavalent Pneumococcal Conjugate Vaccinepneumococcal polysaccharide, type 7Pneumococcal VaccinesPolysaccharides, Bacterialinfantinvasive pneumococcal diseasepneumococcal conjugate vaccineStreptococcus pneumoniae

Identifiers

PMID23733800
PMCPMC3691535
OpenAlexW2051781068

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.